News - page 3 - Healixia

July 20, 2021

Coronavirus: biweekly review of updates to COVID-19 vaccines from 15 July 2021

Source: FAMHP

Coronavirus: tweewekelijks overzicht bijwerkingen COVID-19-vaccins van 15 juli 2021

Coronavirus : aperçu bimensuel des effets indésirables des vaccins contre la COVID-19 du 15 juillet 2021

July 20, 2021

First information session on the new Clinical Trial Regulation (CTR) on 23 September 2021

Source: FAMHP

The FAMHP is organising two information sessions on 23 September 2021 and 25 November 2021.

July 20, 2021

Discontinuation of the telephone contact point of the Marketing Authorisation Division (variations and renewals)

Source: FAMHP

The telephone contact point of the Marketing Authorisation Division (variations and renewals) will be discontinued as of Friday 16 July 2021. The division can still be contacted by email.

July 16, 2021

Coronavirus: take part in the scientific research on the coronavaccines because your experience makes vaccination even safer

Source: FAMHP

Coronavirus: neem deel aan het wetenschappelijk onderzoek over de coronavaccins want uw ervaring maakt vaccineren nog veiliger

Coronavirus : participez à l’étude scientifique sur les vaccins car votre expérience rend la vaccination encore plus sûre

July 16, 2021

Update on ongoing evaluation of COVID-19 vaccines

Source FAMHP

Update on ongoing evaluation of COVID-19 vaccines, EMA advises on COVID-19 Vaccine Janssen and no evidence linking gene therapy Zynteglo to blood cancer

July 12, 2021

Call for all sponsors to publish clinical trial results

Source FAMHP

The FAMHP reminds all sponsors they are obligated to publish the results of their clinical trials in the European Clinical Trials Database (EudraCT) within one year after the end of trial date (or six months for a paediatric trial).

July 12, 2021

The use of contraception after treatment with genotoxic medicines: add recommendations to patient information leaflets

Source FAMHP

The FAMHP reminds marketing authorisation holders of the obligation to add recommendations on the use of contraception to the package leaflet of genotoxic medicines.

July 9, 2021

3rd CRIG industrial partnering event

Source CRIG UGENT

Following the success of its first 2 editions (in 2017 and 2019), the Cancer Research Institute Ghent is pleased to announce the 3^rd CRIG industrial partnering event on Friday 22^nd October 2021.

July 9, 2021

The FAMHP organises two information sessions on the new Clinical Trial Regulation (CTR)

Source FAMHP

FAMHP organises two information sessions, in collaboration with its stakeholders, for sponsors and applicants on 23 September 2021 and on 25 November 2021 on the new Clinical Trial Regulation (CTR).

July 9, 2021

Limited availability of Bleomycine Sanofi 15,000 IU

Source FAMHP

The medicinal product Bleomycine Sanofi 15,000 IU, used in the treatment of certain cancers (testis, throat, mouth, Hodgkin's disease and non-Hodgkin's lymphoma), is currently in limited availability.